Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity

Details for Australian Patent Application No. 2005244207 (hide)

Owner Merck & Co., Inc.

Inventors Mills, Sander G.; Guiadeen, Deodialsingh; Shankaran, Kothandaraman; Morriello, Gregori J.; Yang, Lihu

Agent Spruson & Ferguson

Pub. Number AU-A-2005244207

PCT Pub. Number WO2005/110409

Priority 60/565,382 26.04.04 US

Filing date 22 April 2005

Wipo publication date 24 November 2005

International Classifications

C07D 217/00 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/47 (2006.01) - Quinolines

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110409 Priority application(s): WO2005/110409

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244211-Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies

2005244203-Biodegradable intraocular implants containing prostamides